The Efficacy of SGLT-2 Inhibitor in Patients With CAD and DM Undergoing PCI.
Clinical trial NCT05333159 · UNKNOWN
Trial details
- NCT number
- NCT05333159
- Sponsor
- Beijing Anzhen Hospital
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2021-09-01
- Primary completion
- 2024-12-30
- Enrollment
- 1424
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.